HERTUMAB Trademark

Trademark Overview

On Wednesday, November 11, 2009, a trademark application was filed for HERTUMAB with the United States Patent and Trademark Office. The USPTO has given the HERTUMAB trademark a serial number of 77870573. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 9, 2012. This trademark is owned by Celltrion, Inc.. The HERTUMAB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and compositions for treatment of cancer
hertumab

General Information

Serial Number77870573
Word MarkHERTUMAB
Filing DateWednesday, November 11, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 9, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 13, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and compositions for treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 17, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelltrion, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIncheon
KR
Party NameCelltrion, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIncheon
KR

Trademark Events

Event DateEvent Description
Monday, July 9, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 9, 2012ABANDONMENT - NO USE STATEMENT FILED
Saturday, December 3, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 2, 2011EXTENSION 3 GRANTED
Wednesday, November 30, 2011EXTENSION 3 FILED
Wednesday, November 30, 2011TEAS EXTENSION RECEIVED
Saturday, June 11, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 10, 2011EXTENSION 2 GRANTED
Friday, June 3, 2011EXTENSION 2 FILED
Wednesday, June 8, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 3, 2011TEAS EXTENSION RECEIVED
Tuesday, November 23, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 19, 2010EXTENSION 1 GRANTED
Friday, November 19, 2010EXTENSION 1 FILED
Friday, November 19, 2010TEAS EXTENSION RECEIVED
Tuesday, June 8, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 13, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 13, 2010PUBLISHED FOR OPPOSITION
Tuesday, March 9, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 9, 2010ASSIGNED TO LIE
Wednesday, February 17, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 17, 2010ASSIGNED TO EXAMINER
Tuesday, November 17, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 14, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

hertumab cancer treatment compositions preparations pharmaceutical